Total reported value
$84.5B
Reporting period: 2026-03-31 · Number of holdings: 1
LILLY ENDOWMENT INC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $84.5B and a quarterly turnover rate of 15.9%.
Browse other institutions with $10B to $100B AUMBrowse other institutions starting with "L"
Unchanged LLY
-0.3% -$14.6B
LILLY ENDOWMENT INC trimmed its sole holding LLY while keeping portfolio weight pinned at 100% — this is profit-taking within a singular conviction, not a reduction of the thesis. The endowment is reducing absolute exposure to lock in gains on an overweight winner, yet refuses to dilute the concentrated bet that generated the returns.
The portfolio's exclusive Health Care stance is a bet on the GLP-1 obesity drug cycle and the pricing power of branded pharma. The trim signals the institution is pricing in peak multiples or near-term revenue deceleration, anticipating a regime shift from rapid expansion to maturation. The opposing thesis: regulatory risk on drug pricing or a competitor pipeline breakthrough that erodes LLY's market share.
The single-stock structure creates pure idiosyncratic asymmetry — any clinical trial miss or regulatory setback for LLY's key assets (tirzepatide) forces a portfolio liquidation event. The trim reduces absolute exposure but does nothing to hedge the binary outcome. Moreover, as LLY has been a crowded hedge fund long, a coordinated unwind could accelerate losses well beyond any fundamental trigger.
The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 100.00% | — | -0.32% |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 0% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 1 | $84.5B | 16 | |
| 2025-12-31 | 1 | $99.1B | 30 | |
| 2025-09-30 | 1 | $72.9B | 9 | |
| 2025-06-30 | 1 | $74.8B | 0 | |
| 2025-03-31 | 1 | $79.3B | 100 | |
| 2024-12-31 | 1 | $74.8B | 0 | |
| 2024-09-30 | 1 | $85.8B | 0 | |
| 2024-06-30 | 1 | $88.2B | 0 | |
| 2024-03-31 | 1 | $76.9B | 0 | |
| 2023-12-31 | 1 | $58.2B | 0 | |
| 2023-09-30 | 1 | $53.7B | 0 | |
| 2023-06-30 | 1 | $47.4B | 0 | |
| 2023-03-31 | 1 | $35.2B | 0 | |
| 2022-12-31 | 1 | $37.7B | 0 | |
| 2022-09-30 | 1 | $33.6B | 0 | |
| 2022-06-30 | 1 | $33.8B | 0 | |
| 2022-03-31 | 1 | $30.4B | 0 | |
| 2021-12-31 | 1 | $29.7B | 0 | |
| 2021-09-30 | 1 | $25.0B | 0 | |
| 2021-06-30 | 1 | $25.1B | 90 | |
| 2021-03-31 | 1 | $20.6B | 9 | |
| 2020-12-31 | 1 | $18.8B | 13 | |
| 2020-09-30 | 1 | $16.4B | 11 | |
| 2020-06-30 | 1 | $18.3B | 15 | |
| 2020-03-31 | 1 | $15.7B | 4 | |
| 2019-12-31 | 1 | $15.1B | 14 | |
| 2019-09-30 | 1 | $13.0B | 1 | |
| 2019-06-30 | 1 | $12.9B | 16 | |
| 2019-03-31 | 1 | $15.2B | 10 | |
| 2018-12-31 | 1 | $13.7B | 6 | |
| 2018-09-30 | 1 | $12.8B | 21 | |
| 2018-06-30 | 1 | $10.4B | 9 | |
| 2018-03-31 | 1 | $9.5B | 9 | |
| 2017-12-31 | 1 | $10.4B | 2 | |
| 2017-09-30 | 1 | $10.6B | 3 | |
| 2017-06-30 | 1 | $10.2B | 3 | |
| 2017-03-31 | 1 | $10.5B | 13 | |
| 2016-12-31 | 1 | $9.2B | 9 | |
| 2016-09-30 | 1 | $10.1B | 1 | |
| 2016-06-30 | 1 | $10.0B | 8 | |
| 2016-03-31 | 1 | $9.2B | 16 | |
| 2015-12-31 | 1 | $10.8B | 1 | |
| 2015-09-30 | 1 | $10.8B | 0 | |
| 2015-06-30 | 1 | $10.8B | 13 | |
| 2015-03-31 | 1 | $9.5B | 5 | |
| 2014-12-31 | 1 | $9.1B | 5 | |
| 2014-09-30 | 1 | $8.6B | 3 | |
| 2014-06-30 | 1 | $8.3B | 4 | |
| 2014-03-31 | 1 | $8.0B | 14 | |
| 2013-12-31 | 1 | $6.9B | 1 | |
| 2013-09-30 | 1 | $6.8B | 2 | |
| 2013-06-30 | 1 | $6.7B | 0 |
Lilly Endowment INC's most significant position changes for 2026-03-31: Trim: Eli Lilly & Co (LLY) — shares -0.32%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | — | -0.32% | Trim |
Institutions with a similar AUM
CIK 0001632341
Total reported value
$84.4B
731 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001361570
Total reported value
$84.3B
1,970 stks
2023-06-30
Stale — no recent filing
AUM within 0.2% of this institution
CIK 0001508097
Total reported value
$83.9B
44 stks
2026-03-31
AUM within 0.7% of this institution
Institutions with overlapping top holdings
CIK 0000035527
Total reported value
$54.7B
4,303 stks
2026-03-31
1 of the top 5 holdings overlap, including Eli Lilly & Co
CIK 0000315032
Total reported value
$126.9B
197 stks
2026-03-31
1 of the top 5 holdings overlap, including Eli Lilly & Co
CIK 0000707179
Total reported value
$5.0B
990 stks
2026-06-30
1 of the top 5 holdings overlap, including Eli Lilly & Co